Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.
Steiman AJ, Pope JE, Thiessen-Philbrook H, Li L, Barnabe C, Kalache F, Kung T, Bessette L, Flanagan C, Haraoui B, Hochman J, Leclercq S, Mosher D, Thorne C, Bykerk V. Steiman AJ, et al. Among authors: leclercq s. Rheumatol Int. 2013 May;33(5):1105-20. doi: 10.1007/s00296-012-2619-6. Epub 2013 Jan 6. Rheumatol Int. 2013. PMID: 23292213 Review.
The development of systemic sclerosis classification criteria.
Walker JG, Pope J, Baron M, Leclercq S, Hudson M, Taillefer S, Edworthy SM, Nadashkevich O, Fritzler MJ. Walker JG, et al. Among authors: leclercq s. Clin Rheumatol. 2007 Sep;26(9):1401-9. doi: 10.1007/s10067-007-0537-x. Epub 2007 Feb 7. Clin Rheumatol. 2007. PMID: 17285223 Review.
The cost of systemic sclerosis.
Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, St Pierre Y, Baron M; Canadian Scleroderma Research GroupAdditional members of the Canadian Scleroderma Research Group are shown in Appendix A. Bernatsky S, et al. Among authors: leclercq s. Arthritis Rheum. 2009 Jan 15;61(1):119-23. doi: 10.1002/art.24086. Arthritis Rheum. 2009. PMID: 19116974 Free article.
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, Baron M; Canadian Scleroderma Research Group; Furst DE, Khanna DK, del Junco DJ, Molitor JA, Schiopu E, Phillips K, Seibold JR, Silver RM, Simms RW; GENISOS Study Group; Perry M, Rojo C, Charles J, Zhou X, Agarwal SK, Reveille JD, Assassi S, Arnett FC. Sharif R, et al. J Rheumatol. 2011 Aug;38(8):1622-30. doi: 10.3899/jrheum.110071. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572159 Free PMC article.
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Bombardier C; Canadian Rheumatology Association. Bykerk VP, et al. Among authors: leclercq sa. J Rheumatol. 2012 Aug;39(8):1559-82. doi: 10.3899/jrheum.110207. Epub 2011 Sep 15. J Rheumatol. 2012. PMID: 21921096 Free article.
267 results